Codeine

Codeine

SCHEMBL3477145

COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRD1OPRK1OPRM1

The experimentally established mechanism targets of Codeine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
OPRD1 known ✓ P41143 8/20 0.84
OPRM1 known ✓ P35372 7/20 0.84
OPRK1 known ✓ P41145 5/20 0.84
MRGPRX2 Q96LB1 4/20 0.84
ADRB1 P08588 1/20 0.84
PDE4D Q08499 1/20 0.84
PDE3A Q14432 1/20 0.84
SLC22A1 O15245 1/20 0.65
ADRA2A P08913 1/20 0.65
ARRB1 P49407 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Codeine SCHEMBL3475431 0.95 OPRD1 (0.84) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL3476621 0.94 OPRD1 (0.86) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL3476555 0.93 OPRD1 (0.91) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL1560699 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL21077535 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL13696342 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL10329428 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL3257 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL14371354 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1
Codeine SCHEMBL8218174 0.92 OPRD1 (1.00) OPRD1OPRM1OPRK1MRGPRX2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115078576-A Analysis method of related substances of paracetamol dihydrocodeine tablets 陕西九州制药有限责任公司 2022-09-20 CN disclosed
CN-101579335-B The preparation of medicament and methods for making and using same thereof 阿布拉科斯生物科学有限公司 2016-08-03 CN disclosed
US-20150133664-A1 CHEMICAL TRANSFORMATIONS OF (-)-CODEINE TO AFFORD DERIVATIVES OF CODEINE AND MORPHINE THEREOF UNIV TEXAS (US) 2015-05-14 US disclosed
WO-2013184902-A1 CHEMICAL TRANSFORMATIONS OF (-)-CODEINE TO AFFORD DERIVATIVES OF CODEINE AND MORPHINE THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-12-12 WO disclosed
US-8450365-B2 Efficient synthesis of galanthamine BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-05-28 US disclosed
US-8362283-B2 Cross-conjugated 2,5-cyclohexadienone and related synthesis methods BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-01-29 US disclosed
US-8293927-B2 Efficient synthesis of morphine and codeine BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-10-23 US disclosed
CN-101822841-B Application of organic amine derivatives as brain-targeting modification group of small-molecule drug UNIV SICHUAN 2012-02-15 CN disclosed
WO-2010132570-A1 SYNTHESIS OF MORPHINE AND RELATED DERIVATIVES BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-11-18 WO disclosed
US-20100292489-A1 Cross-conjugated 2,5-cyclohexadienone and related synthesis methods BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2010-11-18 US disclosed
US-20100292466-A1 Efficient Synthesis Of Galanthamine BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM 2010-11-18 US disclosed
US-20100292475-A1 Efficient Synthesis Of Morphine And Codeine BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM 2010-11-18 US disclosed
CN-101822841-A Application of organic amine derivatives as brain-targeting modification group of small-molecule drug UNIV SICHUAN 2010-09-08 CN disclosed
CN-101579335-A New formulation of medicament, preparation method and application method AMERICAN BIOSCIENCE INC (US) 2009-11-18 CN disclosed
CN-100525748-C New preparation of medicine, its preparation and application method AMERICAN BIOSCIENCE INC (US) 2009-08-12 CN disclosed
CN-100462066-C Novel preparation of medicament and preparation and application method thereof VIVORX PHARMACEUTICALS INC (US) 2009-02-18 CN disclosed
CN-1515246-A New preparation of medicine, its preparation and application method �Ϻ���ͨ��ѧ 2004-07-28 CN disclosed
WO-2000072827-A9 POROUS DRUG MATRICES AND METHODS OF MANUFACTURE THEREOF ACUSPHERE INC (US) 2002-01-31 WO disclosed
CN-1267214-A Novel preparation of medicament and preparation and application method thereof VIVORX PHARMACEUTICALS INC (US) 2000-09-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292466-A1 Efficient Synthesis Of Galanthamine GALR2, GALR1, OPRK1 OPRD1 21/4885OPRM1 4/4885OPRK1 3/4885
US-20100292489-A1 Cross-conjugated 2,5-cyclohexadienone and related synthesis methods OPRK1, GALR2, OPRM1 OPRD1 5/4885OPRM1 3/4885OPRK1 1/4885
US-20100292475-A1 Efficient Synthesis Of Morphine And Codeine OPRK1, OPRM1, OPRL1 OPRD1 5/4885OPRM1 2/4885OPRK1 1/4885
US-20150133664-A1 CHEMICAL TRANSFORMATIONS OF (-)-CODEINE TO AFFORD DERIVATIVES OF CODEINE AND MORPHINE THEREOF OPRK1, OPRM1, OPRD1 OPRD1 3/4885OPRM1 2/4885OPRK1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.